Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
DRTS Alpha Tau Medical Ltd
- Stocks
- Healthcare
- NASDAQ: DRTS
Price (delayed)
$3.15
Market cap
$221.7M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.45
Enterprise value
$220.51M
Highlights
The debt has declined by 6% year-on-year
The company's quick ratio fell by 40% YoY and by 33% QoQ
DRTS's equity is down by 26% YoY and by 10% QoQ
Key stats
What are the main financial stats of DRTS
Market
Valuations
Earnings
Shares outstanding
70.38M
Market cap
$221.7M
Enterprise value
$220.51M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.52
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$36.04M
Net income
-$31.75M
EBIT
-$27.45M
EBITDA
-$26.34M
Free cash flow
-$22.02M
Per share
Balance sheet
Liquidity
EPS
-$0.45
EPS diluted
-$0.45
Free cash flow per share
-$0.31
Book value per share
$0.89
Revenue per share
$0
TBVPS
$1.23
Total assets
$86.2M
Total liabilities
$23.54M
Debt
$12.54M
Equity
$62.67M
Working capital
$55.55M
Debt to equity
0.2
Current ratio
7.4
Quick ratio
6.87
Net debt/EBITDA
0.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-33.8%
Return on equity
-44.5%
Return on invested capital
-29.8%
Return on capital employed
-35.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DRTS stock price
How has the Alpha Tau Medical stock price performed over time
Intraday
-3.37%
1 week
-0.63%
1 month
1.94%
1 year
44.5%
YTD
1.61%
QTD
0.96%
Financial performance
How have Alpha Tau Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$36.04M
Net income
-$31.75M
Gross margin
N/A
Net margin
N/A
DRTS's net income is down by 9% year-on-year and by 7% since the previous quarter
Price vs fundamentals
How does DRTS's price correlate with its fundamentals
Growth
What is Alpha Tau Medical's growth rate over time
Valuation
What is Alpha Tau Medical stock price valuation
P/E
N/A
P/B
3.52
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
DRTS's EPS is down by 7% YoY and by 4.7% from the previous quarter
DRTS's P/B is 30% above its last 4 quarters average of 2.7
DRTS's equity is down by 26% YoY and by 10% QoQ
Efficiency
How efficient is Alpha Tau Medical business performance
Alpha Tau Medical's return on invested capital has decreased by 43% YoY and by 27% QoQ
DRTS's ROE is down by 39% YoY and by 15% from the previous quarter
The ROA has contracted by 28% YoY and by 13% from the previous quarter
Dividends
What is DRTS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DRTS.
Financial health
How did Alpha Tau Medical financials performed over time
The company's quick ratio fell by 40% YoY and by 33% QoQ
The current ratio is down by 39% year-on-year and by 33% since the previous quarter
The debt is 80% smaller than the equity
DRTS's equity is down by 26% YoY and by 10% QoQ
DRTS's debt to equity is up by 25% YoY and by 11% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.